This is a Validated Antibody Database (VAD) review about human B3GALT5, based on 7 published articles (read how Labome selects the articles), using B3GALT5 antibody in all methods. It is aimed to help Labome visitors find the most suited B3GALT5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
B3GALT5 synonym: B3GalT-V; B3GalTx; B3T5; GLCT5; beta-1,3-GalTase 5; beta-3-Gx-T5; beta3Gal-T5; beta-1,3-galactosyltransferase 5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5; homolog of C. elegans Bt toxin resistance gene bre-5

BioLegend
rat monoclonal (MC-631)
  • flow cytometry; human; loading ...; fig 1e
BioLegend B3GALT5 antibody (BioLegend, MC-631) was used in flow cytometry on human samples (fig 1e). JCI Insight (2019) ncbi
rat monoclonal (MC-631)
  • immunocytochemistry; scFv; 1:200; loading ...; tbl s4
BioLegend B3GALT5 antibody (Biolegend, MC-631) was used in immunocytochemistry on scFv samples at 1:200 (tbl s4). Stem Cell Res (2016) ncbi
rat monoclonal (MC-631)
  • immunocytochemistry; scFv; 1:200; loading ...; tbl 2
BioLegend B3GALT5 antibody (Biolegend, MC-631) was used in immunocytochemistry on scFv samples at 1:200 (tbl 2). Stem Cell Res (2016) ncbi
rat monoclonal (MC-631)
  • immunocytochemistry; scFv; 1:200; fig 1d
BioLegend B3GALT5 antibody (BioLegend, MC-631) was used in immunocytochemistry on scFv samples at 1:200 (fig 1d). Stem Cell Res (2016) ncbi
rat monoclonal (MC-631)
  • immunocytochemistry; human; tbl 2
BioLegend B3GALT5 antibody (Biolegend, 330307) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
rat monoclonal (MC-631)
  • flow cytometry; scFv; loading ...
BioLegend B3GALT5 antibody (Santa Cruz, 330305) was used in flow cytometry on scFv samples . Mol Hum Reprod (2015) ncbi
rat monoclonal (MC-631)
  • flow cytometry; human
BioLegend B3GALT5 antibody (Biolegend, MC-631) was used in flow cytometry on human samples . J Mol Cell Biol (2011) ncbi
Articles Reviewed
  1. Ruiz Gutierrez M, Bölükbaşı Ö, Alexe G, Kotini A, Ballotti K, Joyce C, et al. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight. 2019;5: pubmed publisher
  2. Hansen S, Stummann T, Borland H, Hasholt L, Tumer Z, Nielsen J, et al. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3. Stem Cell Res. 2016;17:306-317 pubmed publisher
  3. Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11. Stem Cell Res. 2016;16:589-92 pubmed publisher
  4. Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11. Stem Cell Res. 2016;16:553-6 pubmed publisher
  5. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  6. Shpiz A, Kalma Y, Frumkin T, Telias M, Carmon A, Amit A, et al. Human embryonic stem cells carrying an unbalanced translocation demonstrate impaired differentiation into trophoblasts: an in vitro model of human implantation failure. Mol Hum Reprod. 2015;21:271-80 pubmed publisher
  7. Suila H, Pitkänen V, Hirvonen T, Heiskanen A, Anderson H, Laitinen A, et al. Are globoseries glycosphingolipids SSEA-3 and -4 markers for stem cells derived from human umbilical cord blood?. J Mol Cell Biol. 2011;3:99-107 pubmed publisher